-
Je něco špatně v tomto záznamu ?
Childhood cancer survivorship care during the COVID-19 pandemic: an international report of practice implications and provider concerns
SR. van den Oever, SMF. Pluijm, R. Skinner, A. Glaser, RL. Mulder, S. Armenian, E. Bardi, C. Berger, MJ. Ehrhardt, J. Gilleland Marchak, GM. Haeusler, JD. Hartogh, L. Hjorth, T. Kepak, I. Kriviene, T. Langer, M. Maeda, C. Márquez-Vega, G. Michel,...
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
NLK
ProQuest Central
od 2007-06-01 do Před 1 rokem
CINAHL Plus with Full Text (EBSCOhost)
od 2011-03-01 do Před 1 rokem
Medline Complete (EBSCOhost)
od 2011-03-01 do Před 1 rokem
Nursing & Allied Health Database (ProQuest)
od 2007-06-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 2007-06-01 do Před 1 rokem
Psychology Database (ProQuest)
od 2007-06-01 do Před 1 rokem
- MeSH
- COVID-19 * epidemiologie MeSH
- dítě MeSH
- lidé MeSH
- nádory * psychologie MeSH
- pandemie MeSH
- přežívající onkologičtí pacienti * psychologie MeSH
- přežívající MeSH
- Check Tag
- dítě MeSH
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
PURPOSE: Long-term follow-up (LTFU) care is essential to optimise health outcomes in childhood cancer survivors (CCS). We aimed to assess the impact of the COVID-19 pandemic on LTFU services and providers. METHODS: A COVID-19 working group within the International Late Effects of Childhood Cancer Guideline Harmonization Group (IGHG) distributed a questionnaire to LTFU service providers in 37 countries across Europe, Asia, North America, Central/South America, and Australia. The questionnaire assessed how care delivery methods changed during the pandemic and respondents' level of worry about the pandemic's impact on LTFU care delivery, their finances, their health, and that of their family and friends. RESULTS: Among 226 institutions, providers from 178 (79%) responded. Shortly after the initial outbreak, 42% of LTFU clinics closed. Restrictions during the pandemic resulted in fewer in-person consultations and an increased use of telemedicine, telephone, and email consultations. The use of a risk assessment to prioritise the method of LTFU consultation for individual CCS increased from 12 to 47%. While respondents anticipated in-person consultations to remain the primary method for LTFU service delivery, they expected significantly increased use of telemedicine and telephone consultations after the pandemic. On average, respondents reported highest levels of worry about psychosocial well-being of survivors. CONCLUSIONS: The pandemic necessitated changes in LTFU service delivery, including greater use of virtual LTFU care and risk-stratification to identify CCS that need in-person evaluations. IMPLICATIONS FOR CANCER SURVIVORS: Increased utilisation of virtual LTFU care and risk stratification is likely to persist post-pandemic.
City of Hope Comprehensive Cancer Center Duarte CA USA
Danish Cancer Society Research Center Copenhagen Denmark
Department of Epidemiology and Cancer Control St Jude Children's Research Hospital Memphis TN USA
Department of Oncology St Jude Children's Research Hospital Memphis TN USA
Department of Paediatrics Amsterdam UMC Amsterdam The Netherlands
Department of Paediatrics Skåne University Hospital Clinical Sciences Lund University Lund Sweden
Department of Pediatric Hematology and Oncology University Hospitals Leuven Leuven Belgium
Department of Pediatric Oncology Hospital Virgen del Rocío Sevilla Spain
Department of Pediatrics and Adolescent Medicine Kepler University Clinic Linz Austria
Department of Pediatrics Nippon Medical School Tokyo Japan
Division of Haematology Oncology The Hospital for Sick Children Toronto Canada
Epidemiology and Biostatistics Unit and DOPO Clinic IRCCS Istituto Giannina Gaslini Genova Italy
Faculty of Medicine University of Ljubljana Vrazov trg 2 Ljubljana Slovenia
Hospital Tunku Azizah Kuala Lumpur Malaysia
Leeds Institute of Medical Research University of Leeds Leeds LS2 9JT UK
Murdoch Childrens Research Institute Melbourne VIC Australia
Paediatric Integrated Cancer Centre Victoria Australia
Paediatric Oncology Tata Memorial Hospital Mumbai India
Princess Máxima Center for Pediatric Oncology Heidelberglaan 25 3584 CS Utrecht the Netherlands
Radiotherapy department Institute of Oncology Zaloska 2 1000 Ljubljana Slovenia
Republican Siauliai County Hospital Siauliai Lithuania
Royal Childrens Hospital Melbourne VIC Australia
St Anna Childrens Hospital Vienna Austria
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22032534
- 003
- CZ-PrNML
- 005
- 20230131151627.0
- 007
- ta
- 008
- 230120s2022 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s11764-021-01120-9 $2 doi
- 035 __
- $a (PubMed)35020136
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a van den Oever, Selina R $u Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, the Netherlands. s.r.vandenoever-2@prinsesmaximacentrum.nl
- 245 10
- $a Childhood cancer survivorship care during the COVID-19 pandemic: an international report of practice implications and provider concerns / $c SR. van den Oever, SMF. Pluijm, R. Skinner, A. Glaser, RL. Mulder, S. Armenian, E. Bardi, C. Berger, MJ. Ehrhardt, J. Gilleland Marchak, GM. Haeusler, JD. Hartogh, L. Hjorth, T. Kepak, I. Kriviene, T. Langer, M. Maeda, C. Márquez-Vega, G. Michel, M. Muraca, M. Najib, PC. Nathan, A. Panasiuk, M. Prasad, J. Roganovic, A. Uyttebroeck, JF. Winther, L. Zadravec Zaletel, EC. van Dalen, HJH. van der Pal, MM. Hudson, LCM. Kremer, IGHG COVID-19 working group
- 520 9_
- $a PURPOSE: Long-term follow-up (LTFU) care is essential to optimise health outcomes in childhood cancer survivors (CCS). We aimed to assess the impact of the COVID-19 pandemic on LTFU services and providers. METHODS: A COVID-19 working group within the International Late Effects of Childhood Cancer Guideline Harmonization Group (IGHG) distributed a questionnaire to LTFU service providers in 37 countries across Europe, Asia, North America, Central/South America, and Australia. The questionnaire assessed how care delivery methods changed during the pandemic and respondents' level of worry about the pandemic's impact on LTFU care delivery, their finances, their health, and that of their family and friends. RESULTS: Among 226 institutions, providers from 178 (79%) responded. Shortly after the initial outbreak, 42% of LTFU clinics closed. Restrictions during the pandemic resulted in fewer in-person consultations and an increased use of telemedicine, telephone, and email consultations. The use of a risk assessment to prioritise the method of LTFU consultation for individual CCS increased from 12 to 47%. While respondents anticipated in-person consultations to remain the primary method for LTFU service delivery, they expected significantly increased use of telemedicine and telephone consultations after the pandemic. On average, respondents reported highest levels of worry about psychosocial well-being of survivors. CONCLUSIONS: The pandemic necessitated changes in LTFU service delivery, including greater use of virtual LTFU care and risk-stratification to identify CCS that need in-person evaluations. IMPLICATIONS FOR CANCER SURVIVORS: Increased utilisation of virtual LTFU care and risk stratification is likely to persist post-pandemic.
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a přežívající onkologičtí pacienti $x psychologie $7 D000073116
- 650 12
- $a nádory $x psychologie $7 D009369
- 650 12
- $a COVID-19 $x epidemiologie $7 D000086382
- 650 _2
- $a pandemie $7 D058873
- 650 _2
- $a přežívající $7 D017741
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Pluijm, Saskia M F $u Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, the Netherlands
- 700 1_
- $a Skinner, Rod $u Great North Children's Hospital, and Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Newcastle University, Newcastle upon Tyne, UK
- 700 1_
- $a Glaser, Adam $u Leeds Institute of Medical Research, University of Leeds, Leeds, LS2 9JT, UK
- 700 1_
- $a Mulder, Renée L $u Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, the Netherlands
- 700 1_
- $a Armenian, Saro $u City of Hope Comprehensive Cancer Center, Duarte, CA, USA
- 700 1_
- $a Bardi, Edit $u St Anna Childrens Hospital, Vienna, Austria $u Department of Pediatrics and Adolescent Medicine, Kepler University Clinic, Linz, Austria
- 700 1_
- $a Berger, Claire $u Department for Pediatric Hematology and Oncology CHU Nord, University Hospital Saint-Etienne, Saint-Priest en Jarez, France $u U1059 Sainbiose, University Jean Monnet, Saint-Etienne, France
- 700 1_
- $a Ehrhardt, Matthew J $u Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA $u Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN, USA
- 700 1_
- $a Gilleland Marchak, Jordan $u Department of Pediatrics at, Emory University School of Medicine, Aflac Cancer & Blood Disorders Center at Children's Healthcare of Atlanta, Atlanta, GA, USA
- 700 1_
- $a Haeusler, Gabrielle M $u Paediatric Integrated Cancer Centre, Victoria, Australia $u Murdoch Childrens Research Institute, Melbourne, VIC, Australia $u Royal Childrens Hospital, Melbourne, VIC, Australia
- 700 1_
- $a Hartogh, Jaap den $u Dutch Childhood Cancer Parent Organization VOKK Netherlands, Department VOX Survivors, Nieuwegein, The Netherlands
- 700 1_
- $a Hjorth, Lars $u Department of Paediatrics, Skåne University Hospital Clinical Sciences, Lund University, Lund, Sweden
- 700 1_
- $a Kepak, Tomas $u University Hospital Brno & International Clinical Research Center (FNUSA-ICRC), Masaryk University, Brno, Czech Republic
- 700 1_
- $a Kriviene, Izolda $u Republican Siauliai County Hospital, Siauliai, Lithuania $u Vilnius University Siauliai Academy, Siauliai, Lithuania
- 700 1_
- $a Langer, Thorsten $u Pediatric Hematology and Oncology, Hospital for Children and Adolescents, University Hospital of Schleswig-Holstein, Campus Luebeck, Luebeck, Germany
- 700 1_
- $a Maeda, Miho $u Department of Pediatrics, Nippon Medical School, Tokyo, Japan
- 700 1_
- $a Márquez-Vega, Catalina $u Department of Pediatric Oncology, Hospital Virgen del Rocío, Sevilla, Spain
- 700 1_
- $a Michel, Gisela $u Department of Health Sciences and Medicine, University of Lucerne, Frohburgstrasse 3, PO Box 4466, 6002, Lucerne, Switzerland
- 700 1_
- $a Muraca, Monica $u Epidemiology and Biostatistics Unit and DOPO Clinic, IRCCS Istituto Giannina Gaslini, Genova, Italy
- 700 1_
- $a Najib, Mohamed $u Hospital Tunku Azizah, Kuala Lumpur, Malaysia
- 700 1_
- $a Nathan, Paul C $u Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Canada
- 700 1_
- $a Panasiuk, Anna $u Department of Paediatric Bone Marrow Transplantation, Oncology and Haematology, Medical University of Wroclaw, Wroclaw, Poland
- 700 1_
- $a Prasad, Maya $u Paediatric Oncology, Tata Memorial Hospital, Mumbai, India
- 700 1_
- $a Roganovic, Jelena $u Department of Pediatrics, Clinical Hospital Centre Rijeka and School of Medicine of the University of Rijeka, Rijeka, Croatia
- 700 1_
- $a Uyttebroeck, Anne $u Department of Pediatric Hematology and Oncology, University Hospitals Leuven, Leuven, Belgium
- 700 1_
- $a Winther, Jeanette F $u Danish Cancer Society Research Center, Copenhagen, Denmark $u Department of Clinical Medicine, Faculty of Health, Aarhus University and University Hospital, Aarhus, Denmark
- 700 1_
- $a Zadravec Zaletel, Lorna $u Radiotherapy department, Institute of Oncology, Zaloska 2, 1000, Ljubljana, Slovenia $u Faculty of Medicine, University of Ljubljana, Vrazov trg 2, Ljubljana, Slovenia
- 700 1_
- $a van Dalen, Elvira C $u Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, the Netherlands
- 700 1_
- $a van der Pal, Helena J H $u Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, the Netherlands
- 700 1_
- $a Hudson, Melissa M $u Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA $u Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN, USA
- 700 1_
- $a Kremer, Leontien C M $u Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, the Netherlands $u Department of Paediatrics, Amsterdam UMC, Amsterdam, The Netherlands
- 710 2_
- $a IGHG COVID-19 working group
- 773 0_
- $w MED00210173 $t Journal of cancer survivorship $x 1932-2259 $g Roč. 16, č. 6 (2022), s. 1390-1400
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35020136 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230120 $b ABA008
- 991 __
- $a 20230131151623 $b ABA008
- 999 __
- $a ok $b bmc $g 1891351 $s 1183869
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2022 $b 16 $c 6 $d 1390-1400 $e 20220112 $i 1932-2259 $m Journal of cancer survivorship $n J Cancer Surviv $x MED00210173
- LZP __
- $a Pubmed-20230120
